hypercholesterolemia

Showing 1 - 25 of 690

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypercholesterolemia, Primary Prevention Trial in Sao Paulo (Phytosterol supplements)

Completed
  • Hypercholesterolemia
  • Primary Prevention
  • Phytosterol supplements
  • Sao Paulo, Other, Brazil
  • +1 more
Nov 9, 2023

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019

    Not yet recruiting
    • Cardiovascular Diseases
    • +3 more
    • Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
    • New Orleans, Louisiana
      Tulane University
    Sep 26, 2023

    Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

    Not yet recruiting
    • Dyslipidemias
    • +4 more
    • Combination Therapy
    • +5 more
    • (no location specified)
    Aug 22, 2023

    Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)

    Not yet recruiting
    • Hypercholesterolemia
    • Dyslipidemias
    • lipodia
    • Hamburg, Germany
      GAIA AG
    Aug 3, 2023

    Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Familial Hypercholesterolemia
    • (no location specified)
    Jul 10, 2023

    Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Familial Hypercholesterolemia
    • (no location specified)
    Jul 10, 2023

    Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

    Recruiting
    • Hypercholesterolemia
    • K-877 0.2 mg/day (once daily)
    • +2 more
    • Aichi, Japan
    • +14 more
    Jun 20, 2023

    Cardiovascular Diseases, Hypercholesterolemia, Atherosclerosis Trial (PS-containing dietary supplement, Placebo)

    Not yet recruiting
    • Cardiovascular Diseases
    • +2 more
    • PS-containing dietary supplement
    • Placebo
    • (no location specified)
    Jun 2, 2023

    Hyperlipidemias, Hypercholesterolemia Trial in Chios (Chios Mastiha essential oil, Placebo)

    Completed
    • Hyperlipidemias
    • Hypercholesterolemia
    • Chios Mastiha essential oil
    • Placebo
    • Chios, Greece
      Skylitseio General Hospital
    May 11, 2023

    oncRNA Stratification of Cancer by Size and Stage

    Not yet recruiting
    • Kidney Cancer
    • +32 more
    • Exai oncRNA blood test
    • (no location specified)
    Apr 27, 2023

    Hypercholesterolemia Trial in Guanzhou (Swisse plus cholesterol capsule, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Swisse plus cholesterol capsule
    • Placebo
    • Guanzhou, Guangdong, China
      SunYat-senU
    Apr 28, 2023

    Hypercholesterolemia, Obesity, Diabetes Trial (smartphone health application (Opulse))

    Not yet recruiting
    • Hypercholesterolemia
    • +3 more
    • smartphone health application (Opulse)
    • (no location specified)
    Mar 23, 2023

    Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)

    Not yet recruiting
    • Hypercholesterolemia
    • HSK31679 low dose
    • +4 more
    • (no location specified)
    Mar 20, 2023

    Hypercholesterolemia Trial in Sydney, Morayfield, Melbourne (VXX-401, Placebo)

    Recruiting
    • Hypercholesterolemia
    • Sydney, New South Wales, Australia
    • +2 more
    Mar 15, 2023

    Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

    Not yet recruiting
    • Hypercholesterolemia
    • (no location specified)
    Feb 28, 2023

    Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)

    Completed
    • Hypercholesterolemia
    • LIMICOL
    • PLACEBO
    • Clermont-ferrand, France
    • +3 more
    Feb 28, 2023

    Diet-induced Elevations in LDL-C and Progression of

    Recruiting
    • Hypercholesterolemia
      • Torrance, California
        Lundquist Institute for Biomedical Innovation at Harbor UCLA Med
      Feb 17, 2023

      Time Restricted Feeding, Overweight and Obesity, Inflammation Trial in Izola (Effects of calorie restriction and time-restricted

      Recruiting
      • Time Restricted Feeding
      • +8 more
      • Effects of calorie restriction and time-restricted eating on human health
      • Izola, Slovenia
        University of Primorska, Faculty of Health Sciences
      Feb 6, 2023

      Inclisiran and Other Lipid Lowering Treatments inReal-world

      Recruiting
      • Hypercholesterolemia
      • Inclisiran
      • Freudenstadt, Baden Wuerttemberg, Germany
      • +94 more
      Jan 24, 2023

      Hypercholesterolemia Trial in Saint Louis (Bempedoic acid)

      Recruiting
      • Hypercholesterolemia
      • Bempedoic acid
      • Saint Louis, Missouri
        Washington University School of Medicine, Division of Endocrinol
      Jan 12, 2023

      Lipoprotein Metabolism in Normal Volunteers and High Levels of

      Completed
      • Hypolipoproteinemia
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

        Not yet recruiting
        • Hypercholesterolemia
        • +3 more
        • Cambridge, United Kingdom
          University of Cambridge
        Jan 13, 2023

        Cognitive Function in Patients Treated With PCSK9 Inhibitors

        Completed
        • Cognitive Function
        • +2 more
        • PCSK9 inhibitor
        • Cee, A Coruña, Spain
        • +11 more
        Jan 13, 2023

        Hypercholesterolemia Trial in Edmonton (Kefir)

        Completed
        • Hypercholesterolemia
        • Kefir
        • Edmonton, Alberta, Canada
          University of Alberta
        Jan 11, 2023